Patent Issuance Previous Post SanaHeal is awarded $2.3M NIH NIDDK SBIR Direct-to-Phase II grant in collaboration with BIDMC, Harvard Medical School for commercialization of the next-generation solution for diabetic wounds and ulcers. Next Post SanaHeal's patents for on-demand detachable bioadhesive and strain-programmable bioadhesive are issued in the U.S.
